6 assets in Colitis

Therapeutic assets addressing Colitis, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Infliximab Colitis	Therakos LLC	P2	B (63)
Vedolizumab Colitis	Therakos LLC	P2	B (58)
Azathioprine Colitis	Therakos LLC	P2	CCC (53)
VITPSO Colitis	Therakos LLC	P2	CCC (53)
Loperamide Colitis	M.D. Anderson Cancer Center	P1	CC (43)
Prednisone Colitis	M.D. Anderson Cancer Center	P1	CC (43)